Compare $CBIO vs $IRWD | Chartloom

Compare

$CBIO vs $IRWD

Crescent Biopharma Inc · Ironwood Pharmaceuticals Inc

CBIO

Crescent Biopharma Inc

IRWD

Ironwood Pharmaceuticals Inc

Compare $CBIO vs $IRWD

Comparing Crescent Biopharma Inc and Ironwood Pharmaceuticals Inc

CBIOCrescent Biopharma Inc

IRWDIronwood Pharmaceuticals Inc

CBIOCrescent Biopharma Inc

Market cap

$532M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

34.6%

52W performance

23.6%

FCF yield

-28.9%

IRWDIronwood Pharmaceuticals Inc

Market cap

$629M

P/E (TTM)

4.92x

Forward P/E (NTM)

2.96x

Forward P/S (NTM)

1.30x

Rev growth (TTM)

26.2%

YTD performance

-10.5%

52W performance

141.8%

FCF yield

29.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBIO

IRWD

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

CBIO$532M

IRWD$629M

Enterprise Value

CBIO$360M

IRWD$935M

Price

CBIO$14.91

IRWD$3.82

P/E Ratio

CBION/A

IRWD4.92x

P/S Ratio

CBIO44.76x

IRWD1.62x

EV/Sales

CBIO30.32x

IRWD2.40x

EV/EBITDA

CBIO0.00x

IRWD3.93x

P/B Ratio

CBIO3.26x

IRWD0.85x

P/FCF Ratio

CBION/A

IRWD3.39x

EV/FCF

CBIO-2.35x

IRWD5.04x

PEG Ratio

CBION/A

IRWDN/A

Forward P/E (NTM)

CBION/A

IRWD2.96x

Forward P/S (NTM)

CBION/A

IRWD1.30x

Revenue (TTM)

CBIO$12M

IRWD$389M

Revenue Growth (YoY)

CBION/A

IRWD26.2%

Forward Rev Growth

CBIO-15.7%

IRWD6.4%

Gross Margin (TTM)

CBIO0.0%

IRWD100.0%

Operating Margin (TTM)

CBIO0.0%

IRWD60.2%

EBITDA Margin (TTM)

CBIO-1355.3%

IRWD61.1%

Net Margin (TTM)

CBIO-1406.4%

IRWD33.4%

FCF Margin (TTM)

CBIO-1292.8%

IRWD47.7%

Net Income (TTM)

CBIO$-167M

IRWD$130M

FCF (TTM)

CBIO$-154M

IRWD$186M

EPS (TTM)

CBIO-$5.47

IRWD$0.78

ROE (TTM)

CBIO-10026.0%

IRWD29.3%

ROA (TTM)

CBIO-8791.0%

IRWD34.3%

ROIC (TTM)

CBIO-10026.0%

IRWD17.9%

Cash

CBIO$172M

IRWD$79M

Debt

CBIO$0

IRWD$385M

Net Cash/Debt

CBIO$172M

IRWD$-306M

Current Ratio (TTM)

CBIO9.66x

IRWD6.06x

Quick Ratio (TTM)

CBIO9.26x

IRWD5.84x

Debt/Equity (TTM)

CBIO0.00x

IRWD0.56x

Debt/Assets (TTM)

CBIO0.0%

IRWD0.0%

Interest Coverage (TTM)

CBION/A

IRWDN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

IRWD0.00x

Beta

CBIO1.39

IRWD0.22

52W Performance

CBIO23.6%

IRWD141.8%

YTD Performance

CBIO34.6%

IRWD-10.5%

% from 52W High

CBIO-45.6%

IRWD-33.9%

% from 52W Low

CBIO71.0%

IRWD170.9%

Asset Turnover (TTM)

CBIO0.05x

IRWD1.03x

FCF Yield (TTM)

CBIO-28.9%

IRWD29.5%

Earnings Yield (TTM)

CBIO-31.4%

IRWD20.7%

Dividend Yield (TTM)

CBION/A

IRWDN/A

Rule of 40

CBIO-1,292.8

IRWD73.8

EV/GP/RG

CBION/A

IRWD0.10

Ticker research

View CBIO research View IRWD research

Metric	CBIO Crescent Biopharma Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$532M	$629M
Enterprise Value	$360M	$935M
Price	$14.91	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	44.76x	1.62x
EV/Sales	30.32x	2.40x
EV/EBITDA	0.00x	3.93x
P/B Ratio	3.26x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-2.35x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	N/A	1.30x
Revenue & Growth
Revenue (TTM)	$12M	$389M
Revenue Growth (YoY)	N/A	26.2%
Forward Rev Growth	-15.7%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	-1355.3%	61.1%
Net Margin (TTM)	-1406.4%	33.4%
FCF Margin (TTM)	-1292.8%	47.7%
Net Income (TTM)	$-167M	$130M
FCF (TTM)	$-154M	$186M
EPS (TTM)	-$5.47	$0.78
ROE (TTM)	-10026.0%	29.3%
ROA (TTM)	-8791.0%	34.3%
ROIC (TTM)	-10026.0%	17.9%
Financial Health
Cash	$172M	$79M
Debt	$0	$385M
Net Cash/Debt	$172M	$-306M
Current Ratio (TTM)	9.66x	6.06x
Quick Ratio (TTM)	9.26x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	0.22
52W Performance	23.6%	141.8%
YTD Performance	34.6%	-10.5%
% from 52W High	-45.6%	-33.9%
% from 52W Low	71.0%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.03x
FCF Yield (TTM)	-28.9%	29.5%
Earnings Yield (TTM)	-31.4%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	73.8
EV/GP/RG	N/A	0.10
Ticker research	View CBIO research	View IRWD research

Valuation

P/E Ratio

IRWD

4.92x

P/S Ratio

IRWD

1.62x

CBIO

44.76x

EV/FCF

CBIO

-2.35x

IRWD

5.04x

Growth & revenue

Revenue Growth TTM

IRWD

26.2%

Forward Revenue Growth

IRWD

6.4%

CBIO

-15.7%

Profitability & performance

Gross Margin

IRWD

100.0%

CBIO

0.0%

ROE

IRWD

29.3%

CBIO

-10026.0%

FCF Yield %

IRWD

29.5%

CBIO

-28.9%

52-Week Performance

IRWD

141.8%

CBIO

23.6%

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

CBIO$532M

IRWD$629M

Enterprise Value

CBIO$360M

IRWD$935M

Price

CBIO$14.91

IRWD$3.82

P/E Ratio

CBION/A

IRWD4.92x

P/S Ratio

CBIO44.76x

IRWD1.62x

EV/Sales

CBIO30.32x

IRWD2.40x

EV/EBITDA

CBIO0.00x

IRWD3.93x

P/B Ratio

CBIO3.26x

IRWD0.85x

P/FCF Ratio

CBION/A

IRWD3.39x

EV/FCF

CBIO-2.35x

IRWD5.04x

PEG Ratio

CBION/A

IRWDN/A

Forward P/E (NTM)

CBION/A

IRWD2.96x

Forward P/S (NTM)

CBION/A

IRWD1.30x

Revenue (TTM)

CBIO$12M

IRWD$389M

Revenue Growth (YoY)

CBION/A

IRWD26.2%

Forward Rev Growth

CBIO-15.7%

IRWD6.4%

Gross Margin (TTM)

CBIO0.0%

IRWD100.0%

Operating Margin (TTM)

CBIO0.0%

IRWD60.2%

EBITDA Margin (TTM)

CBIO-1355.3%

IRWD61.1%

Net Margin (TTM)

CBIO-1406.4%

IRWD33.4%

FCF Margin (TTM)

CBIO-1292.8%

IRWD47.7%

Net Income (TTM)

CBIO$-167M

IRWD$130M

FCF (TTM)

CBIO$-154M

IRWD$186M

EPS (TTM)

CBIO-$5.47

IRWD$0.78

ROE (TTM)

CBIO-10026.0%

IRWD29.3%

ROA (TTM)

CBIO-8791.0%

IRWD34.3%

ROIC (TTM)

CBIO-10026.0%

IRWD17.9%

Cash

CBIO$172M

IRWD$79M

Debt

CBIO$0

IRWD$385M

Net Cash/Debt

CBIO$172M

IRWD$-306M

Current Ratio (TTM)

CBIO9.66x

IRWD6.06x

Quick Ratio (TTM)

CBIO9.26x

IRWD5.84x

Debt/Equity (TTM)

CBIO0.00x

IRWD0.56x

Debt/Assets (TTM)

CBIO0.0%

IRWD0.0%

Interest Coverage (TTM)

CBION/A

IRWDN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

IRWD0.00x

Beta

CBIO1.39

IRWD0.22

52W Performance

CBIO23.6%

IRWD141.8%

YTD Performance

CBIO34.6%

IRWD-10.5%

% from 52W High

CBIO-45.6%

IRWD-33.9%

% from 52W Low

CBIO71.0%

IRWD170.9%

Asset Turnover (TTM)

CBIO0.05x

IRWD1.03x

FCF Yield (TTM)

CBIO-28.9%

IRWD29.5%

Earnings Yield (TTM)

CBIO-31.4%

IRWD20.7%

Dividend Yield (TTM)

CBION/A

IRWDN/A

Rule of 40

CBIO-1,292.8

IRWD73.8

EV/GP/RG

CBION/A

IRWD0.10

Ticker research

View CBIO research View IRWD research

Metric	CBIO Crescent Biopharma Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$532M	$629M
Enterprise Value	$360M	$935M
Price	$14.91	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	44.76x	1.62x
EV/Sales	30.32x	2.40x
EV/EBITDA	0.00x	3.93x
P/B Ratio	3.26x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-2.35x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	N/A	1.30x
Revenue & Growth
Revenue (TTM)	$12M	$389M
Revenue Growth (YoY)	N/A	26.2%
Forward Rev Growth	-15.7%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	-1355.3%	61.1%
Net Margin (TTM)	-1406.4%	33.4%
FCF Margin (TTM)	-1292.8%	47.7%
Net Income (TTM)	$-167M	$130M
FCF (TTM)	$-154M	$186M
EPS (TTM)	-$5.47	$0.78
ROE (TTM)	-10026.0%	29.3%
ROA (TTM)	-8791.0%	34.3%
ROIC (TTM)	-10026.0%	17.9%
Financial Health
Cash	$172M	$79M
Debt	$0	$385M
Net Cash/Debt	$172M	$-306M
Current Ratio (TTM)	9.66x	6.06x
Quick Ratio (TTM)	9.26x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	0.22
52W Performance	23.6%	141.8%
YTD Performance	34.6%	-10.5%
% from 52W High	-45.6%	-33.9%
% from 52W Low	71.0%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.03x
FCF Yield (TTM)	-28.9%	29.5%
Earnings Yield (TTM)	-31.4%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	73.8
EV/GP/RG	N/A	0.10
Ticker research	View CBIO research	View IRWD research